BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33314787)

  • 21. Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis.
    Chou YH; Lin WC; Chen YM
    Diabetes Res Clin Pract; 2019 Feb; 148():144-151. PubMed ID: 30641169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.
    Fujimori N; Umemura T; Kimura T; Tanaka N; Sugiura A; Yamazaki T; Joshita S; Komatsu M; Usami Y; Sano K; Igarashi K; Matsumoto A; Tanaka E
    World J Gastroenterol; 2018 Mar; 24(11):1239-1249. PubMed ID: 29568204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary autotaxin concentrations are associated with kidney injury.
    Morita Y; Kurano M; Morita E; Shimamoto S; Igarashi K; Sawabe M; Aoki J; Yatomi Y
    Clin Chim Acta; 2020 Oct; 509():156-165. PubMed ID: 32540127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.
    Shariati-Sarabi Z; Ranjbar A; Monzavi SM; Esmaily H; Farzadnia M; Zeraati AA
    Int J Rheum Dis; 2013 Dec; 16(6):731-8. PubMed ID: 24382282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinicopathological correlation among proliferative classes and subclasses of lupus nephritis in renal biopsies].
    Brevis L; Vargas S; Oddó D; Méndez GP
    Rev Med Chil; 2019 Dec; 147(12):1510-1517. PubMed ID: 32186614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.
    Yap DY; Yung S; Zhang Q; Tang C; Chan TM
    Lupus; 2016 Jan; 25(1):46-53. PubMed ID: 26251400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis.
    Diaz-Rizo V; Bonilla-Lara D; Gonzalez-Lopez L; Sanchez-Mosco D; Fajardo-Robledo NS; Perez-Guerrero EE; Rodriguez-Jimenez NA; Saldaña-Cruz AM; Vazquez-Villegas ML; Gomez-Bañuelos E; Vazquez-Del Mercado M; Cardona-Muñoz EG; Cardona-Muller D; Trujillo X; Huerta M; Salazar-Paramo M; Gamez-Nava JI
    PLoS One; 2017; 12(9):e0184056. PubMed ID: 28898254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANCA positivity at the time of renal biopsy is associated with chronicity index of lupus nephritis.
    Pyo JY; Jung SM; Song JJ; Park YB; Lee SW
    Rheumatol Int; 2019 May; 39(5):879-884. PubMed ID: 30806732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
    Li C; Yap DYH; Chan G; Wen YB; Li H; Tang C; Li XM; Li XW; Chan TM
    J Rheumatol; 2019 Nov; 46(11):1478-1484. PubMed ID: 30877215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Relationship between Bilirubin Levels and Patients with Lupus Nephritis.
    He Q; Jiang K; Xie L
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colony-stimulating factor-1: a potential biomarker for lupus nephritis.
    Menke J; Amann K; Cavagna L; Blettner M; Weinmann A; Schwarting A; Kelley VR
    J Am Soc Nephrol; 2015 Feb; 26(2):379-89. PubMed ID: 25012167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mast cells in the kidney biopsies of pediatric patients with lupus nephritis.
    Santos SS; Ramos CM; Monteiro MLGR; Machado JR; Reis MA; Corrêa RRM; Rocha LP
    J Bras Nefrol; 2020 Mar; 42(1):59-66. PubMed ID: 32023339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum thiols as a biomarker of disease activity in lupus nephritis.
    Lalwani P; de Souza GK; de Lima DS; Passos LF; Boechat AL; Lima ES
    PLoS One; 2015; 10(3):e0119947. PubMed ID: 25799079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
    Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
    Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
    Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease in circulating autotaxin by oral administration of prednisolone.
    Sumida H; Nakamura K; Yanagida K; Ohkawa R; Asano Y; Kadono T; Tamaki K; Igarashi K; Aoki J; Sato S; Ishii S; Shimizu T; Yatomi Y
    Clin Chim Acta; 2013 Jan; 415():74-80. PubMed ID: 23063960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI.
    Bruschi M; Sinico RA; Moroni G; Pratesi F; Migliorini P; Galetti M; Murtas C; Tincani A; Madaio M; Radice A; Franceschini F; Trezzi B; Bianchi L; Giallongo A; Gatti R; Tardanico R; Scaloni A; D'Ambrosio C; Carnevali ML; Messa P; Ravani P; Barbano G; Bianco B; Bonanni A; Scolari F; Martini A; Candiano G; Allegri L; Ghiggeri GM
    J Am Soc Nephrol; 2014 Nov; 25(11):2483-98. PubMed ID: 24790181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.